1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, Australia
3.1 Neuromodulation Devices Market, Australia, Revenue ($m), 2018-2033
3.1.1 Implantable Neuromodulation Devices Market, Australia, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
3.2.1 Implantable Neuromodulation Devices Market, Australia, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in Australia, Neuromodulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Nevro Corp
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 LivaNova Plc
4.5.1 Company Overview
4.6 Enterra Medical Inc
4.6.1 Company Overview
4.7 Axonics Inc
4.7.1 Company Overview
4.8 Curonix LLC
4.8.1 Company Overview
4.9 B. Braun Melsungen AG
4.9.1 Company Overview
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 11, 2025: Novel Technique Enhances Brain-State Detection
6.1.2 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
6.2 Product News
6.2.1 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s
6.2.2 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
6.2.3 Oct 24, 2025: IDE Group Announces Winner of the 2025 Building Better Futures for Health Challenge
6.2.4 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression
6.3 Strategy And Business Planning
6.3.1 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 2: Implantable Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Table 4: Implantable Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033
Table 6: Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2025
Table 7: Neuromodulation Devices Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 2: Implantable Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Figure 4: Implantable Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, Australia, Company Share (%), 2025
